Skip to main content

Table 1 Predicted HLA Class II Binding Alleles for the peptides used in this study

From: Profound tumor-specific Th2 bias in patients with malignant glioma

Epitope

Predicted HLA Class II Binding Alleles

MAGE-A3112-127

DRB1*04, *08, *11, *13, DRB5*01

MAGE-A3121-136

DRB1*04, *07, *08, *11, *13, *15, DRB5*01

MAGE-A3143-160

DRB1*01, *03, *04, *07, *08, *11, *13, *15, DRB5*01

IL-13Ra2341-355

DRB1*01, *03, *04, *07, *08, *11, *13, *15, DRB5*01

IL-13Ra2351-365

DRB1*01, *03, *04, *07, *08, *11, *13, *15, DRB5*01

MBP85-99

DRB1*01, *03, *04, *08, *11, *13, *15

  1. Putative HLA-DR binding was determined using the ProPred MHC Class-II binding peptide prediction server, and emphasizes the promiscuous binding of the MAGE-A3 and IL-13Rα2 peptides used in this study.